Brazilian researchers will announce more efficacy data on Tuesday for the coronavirus vaccine made by China's Sinovac, officials said, after medical experts and regulators criticised what they called an incomplete disclosure last week.
Dimas Covas, director of the Butantan biomedical centre, which is running a late-stage trial of the vaccine in Brazil, said ongoing analysis had yielded a new "general efficacy" rate in addition to the "clinical efficacy" announced last week.
On Thursday, Brazilian researchers said the vaccine was shown to be 78 percent effective against mild cases of Covid-19 and entirely prevented severe cases. But independent specialists called for more transparency on the findings from the Phase III trial of the Sinovac vaccine, known as CoronaVac.
Indonesia gave the vaccine emergency use approval on Monday based on interim data showing it is 65 percent effective.
Both the Chinese vaccine and a shot developed by Oxford University and British-Swedish firm AstraZeneca have requests for emergency use authorisation pending with regulators in Brazil, which has lost more than 200,000 lives to the coronavirus pandemic – the worst death toll outside the United States.
Piecemeal disclosure of results from global CoronaVac studies have contributed to concerns that vaccines developed by Chinese producers are not subject to the same public scrutiny as US and European alternatives.
In an interview with news website UOL on Monday, Covas said Butantan, which is funded by Sao Paulo state, had prioritised getting its data to Brazilian health regulator Anvisa and was still analysing the results in parallel.
Covas said the institute would eventually provide its full data to a scientific conference to be announced this week.
Anvisa said on Saturday that a filing from Butantan seeking emergency use authorization for CoronaVac lacked some relevant information for analysis of the study, such as the age, gender and comorbidities of volunteers. (Reuters)
Brazilian team pledges more data on Sinovac jab
2021-01-12 HKT 00:57
2021-03-06 HKT 10:35
2021-03-06 HKT 10:03
2021-03-05 HKT 12:27
2021-03-05 HKT 01:43
2021-03-04 HKT 22:44
2021-03-04 HKT 17:47
2021-02-28 HKT 23:23
2021-02-28 HKT 21:59
2021-02-28 HKT 08:54
2021-02-27 HKT 23:03
2021-02-27 HKT 20:12
2021-02-27 HKT 15:26
2021-02-27 HKT 11:35
2021-02-26 HKT 15:33